{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T12:17:46Z","timestamp":1786709866840,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T00:00:00Z","timestamp":1693180800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T00:00:00Z","timestamp":1693180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiol med"],"DOI":"10.1007\/s11547-023-01705-7","type":"journal-article","created":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T16:04:21Z","timestamp":1693238661000},"page":"1542-1552","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Locally advanced cervical cancer: how the improvement in techniques in external beam radiotherapy and brachytherapy impacts on survival outcomes and long-term toxicities"],"prefix":"10.1007","volume":"128","author":[{"given":"Fernando","family":"Barbera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Frassine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7092-0265","authenticated-orcid":false,"given":"Giulia","family":"Volpi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Ghedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Pasinetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,28]]},"reference":[{"issue":"2","key":"1705_CR1","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","volume":"8","author":"M Arbyn","year":"2020","unstructured":"Arbyn M, Weiderpass E, Bruni L, de Sanjos\u00e9 S, Saraiya M, Ferlay J, Bray F (2020) Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health 8(2):e191\u2013e203. https:\/\/doi.org\/10.1016\/S2214-109X(19)30482-6","journal-title":"Lancet Glob Health"},{"key":"1705_CR2","unstructured":"National Cancer Institute, NIH, Cervix Uteri Cancer, Recent trends in SEER age-adjusted incidence rates 2000\u20132017"},{"key":"1705_CR3","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/0090-8258(90)90072-S","volume":"38","author":"G Delgado","year":"1990","unstructured":"Delgado G, Bundy B, Zaino R, Sevin BU, Creasman WT, Major F (1990) Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 38:352\u2013357","journal-title":"Gynecol Oncol"},{"issue":"10167","key":"1705_CR4","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0140-6736(18)32470-X","volume":"393","author":"PA Cohen","year":"2019","unstructured":"Cohen PA, Jhingran A, Oaknin A, Denny L (2019) Cervical cancer. Lancet 393(10167):169\u2013182. https:\/\/doi.org\/10.1016\/S0140-6736(18)32470-X","journal-title":"Lancet"},{"key":"1705_CR5","unstructured":"Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis. Cochrane Database Syst Rev 2010; 1: CD008285."},{"issue":"3","key":"1705_CR6","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.radonc.2018.03.003","volume":"127","author":"D Cibula","year":"2018","unstructured":"Cibula D, P\u00f6tter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie Meder C, K\u00f6hler C, Landoni F, Lax S, Lindegaard JC, Mahantshetty U, Mathevet P, McCluggage WG, McCormack M, Naik R, Nout R, Pignata S, Ponce J, Querleu D, Raspagliesi F, Rodolakis A, Tamussino K, Wimberger P, Raspollini MR (2018) The European society of gynaecological oncology\/European society for radiotherapy and oncology\/European society of pathology guidelines for the management of patients with cervical cancer. Radiother Oncol 127(3):404\u2013416. https:\/\/doi.org\/10.1016\/j.radonc.2018.03.003","journal-title":"Radiother Oncol"},{"key":"1705_CR7","first-page":"1593","volume-title":"Perez and Brady\u2018s principles and practices of radiation oncology","author":"CA Perez","year":"2008","unstructured":"Perez CA, Kavanagh BD (2008) Uterine cervix. In: Halperin EC, Perez CA, Brady LW (eds) Perez and Brady\u2018s principles and practices of radiation oncology, 5th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1593\u20131595","edition":"5"},{"key":"1705_CR8","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0360-3016(94)90055-8","volume":"28","author":"FD Patel","year":"1994","unstructured":"Patel FD, Sharma SC, Negi PS et al (1994) Low dose rate vs high dose rate brachytherapy in the treatment of carcinoma of the uterine cervix: a clinical trial. Int J Radiat Oncol Biol Phys 28:335\u2013341","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1705_CR9","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/0360-3016(90)90511-H","volume":"19","author":"KK Fu","year":"1990","unstructured":"Fu KK, Phillips TL (1990) High-dose-rate versus low-dose-rate intracavitary brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 19:791\u2013796","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1705_CR10","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/cncr.10207","volume":"94","author":"M Hareyama","year":"2002","unstructured":"Hareyama M, Sakata K, Oouchi A et al (2002) High-dose-rate versus low-dose-rate intracavitary therapy for carcinoma of the uterine cervix: a randomized trial. Cancer 94:117\u2013124","journal-title":"Cancer"},{"key":"1705_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007563.pub3","author":"X Wang","year":"2010","unstructured":"Wang X, Liu R, Ma B et al (2010) High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD007563.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"1705_CR12","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/S0360-3016(99)00262-X","volume":"45","author":"DG Petereit","year":"1999","unstructured":"Petereit DG, Sarkaria JN, Potter DM et al (1999) High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence\u2013the University of Wisconsin experience. Int J Radiat Oncol Biol Phys 45:1267\u20131274","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1705_CR13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.5114\/jcb.2010.16921","volume":"2","author":"J Skowronek","year":"2010","unstructured":"Skowronek J (2010) Pulsed dose rate brachytherapy: is it the right way? J Contemp Brachyther 2:107\u2013113","journal-title":"J Contemp Brachyther"},{"key":"1705_CR14","doi-asserted-by":"publisher","first-page":"20150310","DOI":"10.1259\/bjr.20150310","volume":"88","author":"BV Balgobind","year":"2015","unstructured":"Balgobind BV, Koedooder K, Ordo\u00f1ez Zu\u00f1iga D et al (2015) A re- view of the clinical experience in pulsed dose rate brachyther- apy. Br J Radiol 88:20150310","journal-title":"Br J Radiol"},{"issue":"6","key":"1705_CR15","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1093\/jrr\/rrt072","volume":"54","author":"K Yoshio","year":"2013","unstructured":"Yoshio K, Murakami N, Morota M, Harada K, Kitaguchi M, Yamagishi K, Sekii S, Takahashi K, Inaba K, Mayahara H, Ito Y, Sumi M, Kanazawa S, Itami J (2013) Inverse planning for combination of intracavitary and interstitial brachytherapy for locally advanced cervical cancer. J Radiat Res 54(6):1146\u201352. https:\/\/doi.org\/10.1093\/jrr\/rrt072","journal-title":"J Radiat Res"},{"issue":"1","key":"1705_CR16","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/s0360-3016(01)01664-9","volume":"51","author":"L Portelance","year":"2001","unstructured":"Portelance L, Chao KS, Grigsby PW, Bennet H, Low D (2001) Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys 51(1):261\u2013266. https:\/\/doi.org\/10.1016\/s0360-3016(01)01664-9","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"1705_CR17","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.radonc.2004.12.015","volume":"74","author":"C Haie-Meder","year":"2005","unstructured":"Haie-Meder C, P\u00f6tter R, Van Limbergen E, Briot E, De Brabandere M, Dimopoulos J, Dumas I, Hellebust TP, Kirisits C, Lang S, Muschitz S, Nevinson J, Nulens A, Petrow P, WachterGerstner N (2005) Gynaecological (GYN) GEC-ESTRO Working Group. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 74(3):235\u201345. https:\/\/doi.org\/10.1016\/j.radonc.2004.12.015","journal-title":"Radiother Oncol"},{"issue":"1","key":"1705_CR18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.radonc.2005.11.014","volume":"78","author":"R P\u00f6tter","year":"2006","unstructured":"P\u00f6tter R, Haie-Meder C, Van Limbergen E, Barillot I, De Brabandere M, Dimopoulos J, Dumas I, Erickson B, Lang S, Nulens A, Petrow P, Rownd J, Kirisits C (2006) GEC ESTRO Working Group. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol. 78(1):67\u201377. https:\/\/doi.org\/10.1016\/j.radonc.2005.11.014","journal-title":"Radiother Oncol."},{"issue":"1","key":"1705_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.brachy.2011.07.002","volume":"11","author":"AN Viswanathan","year":"2012","unstructured":"Viswanathan AN, Beriwal S, De Los Santos JF, Demanes DJ, Gaffney D, Hansen J, Jones E, Kirisits C, Thomadsen B, Erickson B (2012) American Brachytherapy Society. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy. Brachytherapy 11(1):47\u201352. https:\/\/doi.org\/10.1016\/j.brachy.2011.07.002","journal-title":"Brachytherapy"},{"key":"1705_CR20","unstructured":"National cancer institute: common terminology criteria for adverse events v 5.0. Available at https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/ctcae_v5_quick_reference_5x7.pdf"},{"key":"1705_CR21","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1056\/NEJM199904153401502","volume":"340","author":"PG Rose","year":"1999","unstructured":"Rose PG, Bundy BN, Watkins EB et al (1999) Concurrent cisplatin-based radiotherapy and chemotherapy for locally advaced cervical cancer. N Engl J Med 340:1144\u20131153","journal-title":"N Engl J Med"},{"issue":"16","key":"1705_CR22","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1200\/JCO.2017.75.9985","volume":"36","author":"S Gupta","year":"2018","unstructured":"Gupta S, Maheshwari A, Parab P, Mahantshetty U, Hawaldar R, Sastri Chopra S, Kerkar R, Engineer R, Tongaonkar H, Ghosh J, Gulia S, Kumar N, Shylasree TS, Gawade R, Kembhavi Y, Gaikar M, Menon S, Thakur M, Shrivastava S, Badwe R (2018) Neoadjuvant chemotherapy followed by radical surgery versus concomitant chemotherapy and radiotherapy in patients with stage IB2, IIA, or IIB squamous cervical cancer: a randomized controlled trial. J Clin Oncol 36(16):1548\u20131555. https:\/\/doi.org\/10.1200\/JCO.2017.75.9985","journal-title":"J Clin Oncol"},{"issue":"1","key":"1705_CR23","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ygyno.2011.12.432","volume":"125","author":"XL Du","year":"2012","unstructured":"Du XL, Tao J, Sheng XG, Lu CH, Yu H, Wang C, Song QQ, Li QS, Pan CX (2012) Intensitymodulated radiation therapy for advanced cervical cancer: a comparison of dosimetric and clinical outcomes with conventional radiotherapy. Gynecol Oncol 125(1):151\u2013157. https:\/\/doi.org\/10.1016\/j.ygyno.2011.12.432","journal-title":"Gynecol Oncol"},{"issue":"1","key":"1705_CR24","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s13014-018-1126-7","volume":"13","author":"Y Lin","year":"2018","unstructured":"Lin Y, Chen K, Lu Z, Zhao L, Tao Y, Ouyang Y, Cao X (2018) Intensity-modulated radiation therapy for definitive treatment of cervical cancer: a meta-analysis. Radiat Oncol 13(1):177. https:\/\/doi.org\/10.1186\/s13014-018-1126-7","journal-title":"Radiat Oncol"},{"issue":"3","key":"1705_CR25","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.ijrobp.2013.06.2059","volume":"87","author":"AK Gandhi","year":"2013","unstructured":"Gandhi AK, Sharma DN, Rath GK, Julka PK, Subramani V, Sharma S, Manigandan D, Laviraj MA, Kumar S, Thulkar S (2013) Early clinical outcomes and toxicity of intensity modulated versus conventional pelvic radiation therapy for locally advanced cervix carcinoma: a prospective randomized study. Int J Radiat Oncol Biol Phys 87(3):542\u2013548. https:\/\/doi.org\/10.1016\/j.ijrobp.2013.06.2059","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"1705_CR26","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/1748-717X-7-197","volume":"23","author":"B Yang","year":"2012","unstructured":"Yang B, Zhu L, Cheng H, Li Q, Zhang Y, Zhao Y (2012) Dosimetric comparison of intensity modulated radiotherapy and three-dimensional conformal radiotherapy in patientswith gynecologic malignancies: a systematic review and meta-analysis. Radiat Oncol 23(7):197. https:\/\/doi.org\/10.1186\/1748-717X-7-197","journal-title":"Radiat Oncol"},{"issue":"5","key":"1705_CR27","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.ijrobp.2010.04.041","volume":"80","author":"MD Hasselle","year":"2011","unstructured":"Hasselle MD, Rose BS, Kochanski JD, Nath SK, Bafana R, Yashar CM, Hasan Y, Roeske JC, Mundt AJ, Mell LK (2011) Clinical outcomes of intensity-modulated pelvic radiation therapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 80(5):1436\u20131445. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.04.041","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"1705_CR28","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1200\/JCO.2002.20.4.966","volume":"20","author":"R Pearcey","year":"2002","unstructured":"Pearcey R, Brundage M, Drouin P, Jeffrey J, Johnston D, Lukka H, MacLean G, Souhami L, Stuart G, Tu D (2002) Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. J Clin Oncol 20(4):966\u2013972. https:\/\/doi.org\/10.1200\/JCO.2002.20.4.966","journal-title":"J Clin Oncol"},{"issue":"5","key":"1705_CR29","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.ijrobp.2018.11.012","volume":"103","author":"AJ Lin","year":"2019","unstructured":"Lin AJ, Kidd E, Dehdashti F, Siegel BA, Mutic S, Thaker PH, Massad LS, Powell MA, Mutch DG, Markovina S, Schwarz J, Grigsby PW (2019) Intensity modulated radiation therapy and image-guided adapted brachytherapy for cervix cancer. Int J Radiat Oncol Biol Phys 103(5):1088\u20131097. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.11.012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1705_CR30","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S0360-3016(98)00482-9","volume":"43","author":"MD Logsdon","year":"1999","unstructured":"Logsdon MD, Eifel PJ (1999) FIGO IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiationtherapy. Int J Radiat Oncol Biol Phys 43:763\u2013775","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"1705_CR31","doi-asserted-by":"publisher","first-page":"287","DOI":"10.5114\/jcb.2022.117727","volume":"14","author":"L Russo","year":"2022","unstructured":"Russo L, Lancellotta V, Micc\u00f2 M, Fionda B, Avesani G, Rovirosa A, Wojcieszek P, Scambia G, Manfredi R, Tagliaferri L, Gui B (2022) Magnetic resonance imaging in cervical cancer interventional radiotherapy (brachytherapy): a pictorial essay focused on radiologist management. J Contemp Brachyther 14(3):287\u2013298. https:\/\/doi.org\/10.5114\/jcb.2022.117727","journal-title":"J Contemp Brachyther"},{"issue":"4","key":"1705_CR32","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/S1470-2045(20)30753-1","volume":"22","author":"R P\u00f6tter","year":"2021","unstructured":"P\u00f6tter R, Tanderup K, Schmid MP, J\u00fcrgenliemk-Schulz I, Haie-Meder C, Fokdal LU, Sturdza AE, Hoskin P, Mahantshetty U, Segedin B, Bruheim K, Huang F, Rai B, Cooper R, van der Steen-Banasik E, Van Limbergen E, Pieters BR, Tan LT, Nout RA, De Leeuw AAC, Ristl R, Petric P, Nesvacil N, Kirchheiner K, Kirisits C, Lindegaard JC, EMBRACE Collaborative Group (2021) MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study. Lancet Oncol 22(4):538\u2013547. https:\/\/doi.org\/10.1016\/S1470-2045(20)30753-1","journal-title":"Lancet Oncol"},{"issue":"3","key":"1705_CR33","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.ygyno.2016.09.017","volume":"143","author":"LP Cho","year":"2016","unstructured":"Cho LP, Manuel M, Catalano P, Lee L, Damato AL, Cormack RA, Buzurovic I, Bhagwat M, O\u2019Farrell D, Devlin PM, Viswanathan AN (2016) Outcomes with volume-based dose specification in CT-planned high-dose-rate brachytherapy for stage I-II cervical carcinoma: a 10-year institutional experience. Gynecol Oncol 143(3):545\u2013551. https:\/\/doi.org\/10.1016\/j.ygyno.2016.09.017","journal-title":"Gynecol Oncol"},{"issue":"1","key":"1705_CR34","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.brachy.2016.09.011","volume":"16","author":"J Karlsson","year":"2017","unstructured":"Karlsson J, Dreifaldt AC, Mordhorst LB, Sorbe B (2017) Differences in outcome for cervical cancer patients treated with or without brachytherapy. Brachytherapy 16(1):133\u2013140. https:\/\/doi.org\/10.1016\/j.brachy.2016.09.011","journal-title":"Brachytherapy"},{"issue":"9","key":"1705_CR35","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.7150\/jca.23974","volume":"9","author":"YZ Dang","year":"2018","unstructured":"Dang YZ, Li P, Li JP, Bai F, Zhang Y, Mu YF, Li WW, Wei LC, Shi M (2018) The efficacy and late toxicities of computed tomography-based brachytherapy with intracavitary and interstitial technique in advanced cervical cancer. J Cancer 9(9):1635\u20131641. https:\/\/doi.org\/10.7150\/jca.23974","journal-title":"J Cancer"},{"issue":"9","key":"1705_CR36","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s00066-021-01887-x","volume":"198","author":"R Vojt\u00ed\u0161ek","year":"2022","unstructured":"Vojt\u00ed\u0161ek R, Ho\u0161ek P, Sukovsk\u00e1 E, Kov\u00e1\u0159ov\u00e1 P, Baxa J, Ferda J, F\u00ednek J (2022) Treatment outcomes of MRI-guided adaptive brachytherapy in patients with locally advanced cervical cancer: institutional experiences. Strahlenther Onkol 198(9):783\u2013791. https:\/\/doi.org\/10.1007\/s00066-021-01887-x","journal-title":"Strahlenther Onkol"},{"issue":"9","key":"1705_CR37","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3390\/medicina58091223","volume":"58","author":"F Tramacere","year":"2022","unstructured":"Tramacere F, Lancellotta V, Cas\u00e0 C, Fionda B, Cornacchione P, Mazzarella C, De Vincenzo RP, Macchia G, Ferioli M, Rovirosa A, Gambacorta MA, Colosimo C, Valentini V, Iezzi R, Tagliaferri L (2022) Assessment of sexual dysfunction in cervical cancer patients after different treatment modality: a systematic review. Medicina (Kaunas) 58(9):1223. https:\/\/doi.org\/10.3390\/medicina58091223","journal-title":"Medicina (Kaunas)"},{"key":"1705_CR38","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-023-03099-4","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Noorian F, Abellana R, Rochera J, Herreros A, Antelo G, Lancellotta V, Tagliaferri L, Han Q, Torne A, Rovirosa A (2023) Vaginal dilator use more than 9 months is a main prognostic factor for reducing G2-late vaginal complications in 3D-vaginal-cuff brachytherapy (interventional radiotherapy)? Clin Transl Oncol. https:\/\/doi.org\/10.1007\/s12094-023-03099-4","journal-title":"Clin Transl Oncol"}],"container-title":["La radiologia medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-023-01705-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11547-023-01705-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-023-01705-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T14:06:33Z","timestamp":1701871593000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11547-023-01705-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,28]]},"references-count":38,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1705"],"URL":"https:\/\/doi.org\/10.1007\/s11547-023-01705-7","relation":{},"ISSN":["1826-6983"],"issn-type":[{"value":"1826-6983","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,28]]},"assertion":[{"value":"2 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Brescia (October 15, 2019); study number 3769.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}